HCV 6a Prevalence in Guangdong Province Had the Origin from Vietnam and Recent Dissemination to Other Regions of China: Phylogeographic Analyses by Fu, Yongshui et al.
HCV 6a Prevalence in Guangdong Province Had the
Origin from Vietnam and Recent Dissemination to Other
Regions of China: Phylogeographic Analyses
Yongshui Fu
1,2., Weibing Qin
3,4., Hong Cao
5,R uX u
2, Yi Tan
6, Teng Lu
7, Hongren Wang
4, Wangxia
Tong
5, Xia Rong
2, Gang Li
4, Manqiong Yuan
8, Chunhua Li
8, Kenji Abe
9, Ling Lu
8,10*, Guihua Chen
10
1Department of Biochemistry, Medical College of Sun Yat-sen University, Guangzhou, Guangdong, China, 2Guangzhou Blood Center, Guangzhou, Guangdong, China,
3Family Planning Research Institute of Guangdong Province, Guangzhou, Guangdong, China, 4The Vaccine Institute, Third Affiliated Hospital of Sun Yat-sen University,
Guangzhou, Guangdong, China, 5Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China, 6Fogarty
International Center, National Institutes of Health, Bethesda, Maryland, United States of America, 7University of Southern California, Los Angeles, California, United States
of America, 8Department of Pathology and Laboratory Medicine, Viral Oncology Center, University of Kansas Medical Center, Kansas City, Kansas, United States of
America, 9Department of Pathology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan, 10Laboratory for Hepatology, Third Affiliated Hospital of Sun
Yat-sen University, Guangzhou, Guangdong, China
Abstract
Background: Recently in China, HCV 6a infection has shown a fast increase among patients and blood donors, possibly due
to IDU linked transmission.
Methodology/Findings: We recruited 210 drug users in Shanwei city, Guangdong province. Among them, HCV RNA was
detected in 150 (71.4%), both E1 and NS5B genes were sequenced in 136, and 6a genotyped in 70. Of the 6a sequences,
most were grouped into three clusters while 23% represent emerging strains. For coalescent analysis, additional 6a
sequences were determined among 21 blood donors from Vietnam, 22 donors from 12 provinces of China, and 36 IDUs
from Liuzhou City in Guangxi Province. Phylogeographic analyses indicated that Vietnam could be the origin of 6a in China.
The Guangxi Province, which borders Vietnam, could be the first region to accept 6a for circulation. Migration from Yunnan,
which also borders Vietnam, might be equally important, but it was only detected among IDUs in limited regions. From
Guangxi, 6a could have further spread to Guangdong, Yunnan, Hainan, and Hubei provinces. However, evidence showed
that only in Guangdong has 6a become a local epidemic, making Guangdong the second source region to disseminate 6a
to the other 12 provinces. With a rate of 2.737610
23 (95% CI: 1.792610
23 to 3.745610
23), a Bayesian Skyline Plot was
portrayed. It revealed an exponential 6a growth during 1994–1998, while before and after 1994–1998 slow 6a growths were
maintained. Concurrently, 1994–1998 corresponded to a period when contaminated blood transfusion was common, which
caused many people being infected with HIV and HCV, until the Chinese government outlawed the use of paid blood
donations in 1998.
Conclusions/Significance: With an origin from Vietnam, 6a has become a local epidemic in Guangdong Province, where an
increasing prevalence has subsequently led to 6a spread to many other regions of China.
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Introduction
Because of frequent blood exposures and unsafe injection
behaviors, hepatitis C virus (HCV) infection has become highly
prevalent among injection drug users (IDU) in China [1–4]. Based
on a recent meta-analysis, the pooled HCV prevalence among
IDUs was about 67.6%, and there were large geographic variations
in genotype distribution. Generally, 6a was predominant, account-
ing for 36.7%. This was followed by 3b, 1a, 3a, and 1b, accounting
for 16.4%, 14.6%, 12.8%, and 12.4%, respectively [5]. Among
IDUs in the Guangxi and Hubei Provinces, and in Hong Kong and
Taiwan as well, 6a was the main HCV strain [5]. However, this was
not consistent with the predominant strains among clinical patients.
The high proportion of 6a among IDUs in Guangxi has been linked
to the fact that HCV was transmitted through unsafe injection by
users along the drug trafficking route from Southeast Asia [6].
The Guangdong Province is located in the southern part of
China, neighboring Guangxi. Historically, it has been an internal
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changes. Since 1978, Guangdong has been assigned as the first
region of China to adopt a free market economy and open door
policy. Recently, as economic development in China accelerates,
this province has become a ‘‘World Production Center’’. A
powerful economy has stimulated a large population of drug users
and a rapid increase in drug trafficking and trading. In addition,
there has been an explosion of the illegal sex industry in the
province and this has been associated with millions of migrants
who are on business or pleasure or temporarily hired as laborers in
the myriad of factories that lack good hygiene conditions [7].
Collectively, these factors have created an environment to inbreed
HCV prevalence.
Recently, we have studied HCV infection among patients and
blood donors in the Guangdong Province and found that 6a has
accounted for an increasing proportion [8–9]. We tend to believe
that this 6a prevalence could have resulted from IDU linked
transmission. In our phylogenetic analysis, 6a appeared to show its
origin from Vietnam, because Vietnamese isolates were the most
diverse and genetically distant. Considering the historical event in
which the Guangdong, Guangxi, and Hainan provinces had
accepted approximately 300,000 refugees from Vietnam during
the late 1970 s [9], we hypothesized that 6a may have since been
introduced into Guangdong and become a local epidemic to seed
the IDU network. In recent decades, 6a has been spread to other
regions by IDUs or by infected people among the migrants. In this
study, coalescent and phylogeographic analyses were performed to
test this hypothesis.
Results
Prevalence of anti-HCV and HCV RNA
For routinely screening blood donations, an automated,
integrated NAT (Nucleic Acid Testing) platform has been
implemented at the Guangzhou Blood Center. Therefore, samples
from this study were first applied to this platform. After testing for
HCV RNA, the samples were subjected to PCR. This resulted
with only 198 samples left for anti-HCV assay. Consequently,
191/198 (94.5%) users were anti-HCV positive and 150/210
(71.4%) were HCV RNA positive (Table 1).
HCV sequence amplification and phylogenetic analysis
Of the 150 users positive for HCV RNA, both E1 and NS5B
genes were amplified in 136 (90.7%) but failed in 14 (9.3%). Thus,
HCV was genotyped: 6a in 70 (51.5%), 3a in 42 (30.9%), 1b in 13
(9.6%), 3b in 3 (1.6%), and multiple HCV infections in 8 users
(5.9%) (Table 2).
1b sequences were isolated from 13 users. Among them one was
classified into a previously designated ‘‘A’’ cluster, three into a ‘‘C’’
cluster [9], and one was grouped with reference Chinese isolates.
In contrast, eight formed their own cluster designated ‘‘SW’’. The
SW had a bootstrap score of 95% in the E1 and 89% in the NS5B
tree (Figure S1).
3a sequences were isolated from 42 users. They formed a
monophyletic cluster in both the E1 and NS5B trees (Figure S2).
Genetically, they looked distinct from those isolated from IDUs in
the Hubei [2] and Yunnan Provinces [10] but with no significant
bootstrap support.
6a sequences were isolated from 70 users. Among them, 28, 5,
and 17 were classified into clusters I, II, and III; 8 each were
grouped into clusters VI and VII (Figure 1). Clusters I, II, and III
have been recently described and included many reference
sequences [2,3,6,8,9]. Clusters VI and VII were newly designated
and contained sequences only from this study (accounting for
23%). Both the E1 and NS5B sequences were analyzed and
classified isolates consistently. Therefore, identical isolates were
placed in similar positions in both trees. The E1 tree further
showed bootstrap scores of 82%, 95%, 88%, 92%, and 90% for
clusters I, II, III, VI, and VII, respectively. However, no significant
scores were shown in the NS5B tree.
Multiple HCV infections
Directly sequencing amplicons yielded ambiguous results for
eight users. Molecular cloning followed by sequencing revealed
that they had multiple infections with different HCV strains. This
was confirmed by sequencing both E1 and NS5B genes from two
users, sequencing both core and E1 from one, and sequencing
single NS5B from five. SW33, SW62, SW64, SW109, and SW179
each had co-infection with two 6a strains, of which SW64 and
SW109 also had a third strain of 1b. SW122 had co-infection with
Table 1. Positive rates of anti-HCV and HCV RNA among drug
users.
Anti-HCV HCV RNA
Total Positive % Total Positive %
Age ,20 6 6 100 6 2 33.3
21–30 62 60 98.4 68 46 67.7
31–40 109 104 95.4 114 82 71.9
41–50 18 18 100 18 16 88.9
.50 3 3 100 4 4 100
Gender Male 188 181 96.2 200 142 71.0
Female 10 10 100 10 8 80.0
Marriage Married 82 78 95.1 86 60 69.8
Not married 116 113 97.4 124 90 72.6
Origin Guangdong 186 180 96.8 198 142 71.7
Not
Guangdong
12 11 91.7 12 8 66.7
Education $High school 38 37 97.4 40 29 72.5
Middle school 77 74 96.1 83 60 72.3
#Elementary 83 80 96.4 87 61 70.1
Job Jobless 103 99 96.1 109 77 70.6
Had a job 95 92 96.8 101 73 72.3
Surgery history Yes 38 37 97.4 42 33 78.6
No 160 154 96.3 168 117 69.6
Transfusion
history
Yes 21 20 95.2 22 16 72.7
No 177 171 96.6 188 134 71.3
Injection
drug use
Yes 176 172 97.7 185 144 77.8
No 22 19 86.4 25 6 24.0
Years of drug use ,2 48 47 97.9 49 31 63.3
2–5 30 29 96.7 35 21 60.0
6–10 68 66 97.1 72 55 76.4
.10 52 49 94.2 54 43 79.6
Years of injection ,1 40 40 100 41 33 80.5
1–5 45 42 94.4 50 40 80.0
6–10 47 46 97.9 49 40 81.6
.10 44 44 100 45 37 82.2
doi:10.1371/journal.pone.0028006.t001
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(Table 3).
Coalescent analyses of 6a sequences
(1) 285 dated sequences. Many 6a sequences have been
reported among IDUs in China [2,3,6,10]. We have also
characterized a number of 6a sequences from patients and blood
donors in the Guangdong Province [8,9]. Jointly, they represented
139 retrieved sequences. Here, 6a sequences were further
determined among 21 blood donors from Vietnam, 22 blood
donors from 12 provinces of China, and 36 IDUs [3] from
Liuzhou City in Guangxi Province. They were co-analyzed with
those from 70 IDUs in Shanwei city. In total, 285 isolates were
represented, each with 519 nt of E1 gene.
(2) Model test. Prior to coalescent analysis [11], model test
was performed [12]. Based on BIC (Bayesian information
criterion) and AIC (Akaike information criterion), the GTR+I+C
model was found to be the best. However, based on AICc (Akaike
information criterion, corrected), the K80+C model was the best.
Compared to AIC and BIC, AICc favors simpler models by
scoring higher penalties for extra parameters. Since in the BEAST
package [13] the model complexity is endeavored and K80+C is
not implemented, we selected the GTR+I+C model.
(3) Initial coalescent analyses. Initial coalescent analyses
were performed directly with the 285 sequences. After running
MCMC (Markov Chains Monte Carlo) for 200 million states
under three models, BSP + uncorrelated exponential, BSP +
uncorrelated lognormal, and BSP + strict clock, respectively, the
mean substitution rates, 1.753610
23 (95% CI: 2.3321610
24 to
3.5632610
23), 2.4472610
23 (95% CI: 1.8745610
23 to
3.1487610
23), and 1.69610
23 (95% CI: 1.1033610
23 to
2.231610
23) per site per year, were estimated. Although the
exponential model was shown to be better than lognormal
(measured by Bayesian Factor, BF.15) and strict models
(BF.72.6), three resulting statistics (posterior, mean.Rate,
uced.mean) lacked effective sample sizes (ESS#20). In addition,
it showed two separate peaks of trace distribution for the rate and
a high COV (coefficient of variation) (mean=0.879, 95%CI:
0.8191 to 0.9417), both of which might suggest different
substitution rates between the Chinese and Vietnamese lineages,
consistent with a previous report [14].
(4) Estimating rates as priors. To obtain more valid rates
to be used as priors in subsequent analysis for better representing
the Chinese isolates, 139 sequences were selected with exclusion of
all the Vietnamese strains. The 139 sequences were from our
studies to ensure correct sampling dates and provide good
temporal and phylogenetic structures. Under three models: BSP
+ uncorrected exponential, BSP + uncorrected lognormal, and
BSP + strict clock, the substitution rates, 2.737610
23 (95% CI:
1.792610
23 to 3.745610
23), 2.0615610
23 (95% CI:
1.4786610
23 to 2.8687610
23), and 7.778610
24 (95% CI:
8.1928610
25 to 1.7478610
23) were estimated. Possibly because
a short and recent time interval (2002 to 2009) was covered by the
139 sequences, great differences were observed among the rates.
However, sufficient ESS was achieved for all statistics. BF analysis
confirmed that the exponential model was better than lognormal
(BF=57.75) and lognormal better than the strict (BF=8.42).
(5) Coalescent analyses using rates as priors. Using the
rate 2.737610
23 (95% CI: 1.792610
23 to 3.745610
23, standard
error: 1.507610
25) as a prior under the BSP + uncorrected
exponential model, a coalescent analysis was performed for the
285 sequences (Table 4). Transforming the log file into trace
distributions revealed a substitution rate of 2.7346610
23 (95% CI:
2.7055610
23 to 2.7637610
23), in which the mean is similar to the
prior but the 95% CI (confidence interval) is narrower. Parameter
a is inversely related to the extent of rate variation among sites
[15]. Here, the estimated a was 0.8933 (95%CI: 0.8887 to 0.8978).
It is #1 and means that most sites have very low rates while
mutational ‘‘hot spots’’ existed in the sequences that changed at
very high rates. Compared to that previously estimated for core
(a=0.22) and NS5B (a=0.32) genes [14], a higher a suggests a
weaker ‘‘hot spot’’ pattern for the analyzed E1 gene. The pInv
statistic shows the proportion of invariable sites and lower value
means more variable nucleotides [16]. Here, a moderate pInv
0.4684 (95%CI: 0.4674 to 0.4695) was inferred. COV represents
rate heterogeneity among lineages, which abuts zero when a strict
molecular clock is followed [17]. For the 285 sequences a high
COV, 0.8419 (95% CI: 0.8402 to 0.8437), was estimated. This is
higher than 0.37 previously inferred for concatenated core and
NS5B genes (95% CI: 0.28 to 0.45) [14] and strongly indicates a
relaxed molecular clock. In addition, a very small covariance
parameter, 5.652610
24 (95% CI: 20.0011 to 2.2368610
23), was
observed. This value measures a degree to which among-lineage
rate variation is randomly distributed across the phylogeny rather
than being restricted to specific clusters. Using different rates as
priors, coalescent analyses were also performed under two other
models, BSP + uncorrected lognormal and BSP + strict clock, and
the results were detailed in Table 4.
(6) Phylogeography. Figure 2 shows the MCC (maximum
clade credibility) tree, a phylogeography reconstructed from the
trees sampled under the exponential model (Table 4). Seven 6a
clusters shown in Figure 1 are all maintained and supported with
high posterior probabilities (P$0.97). Vietnamese isolates are
positioned at the base. The base contains the most direct
descendents of the earliest 6a common ancestor dated around
1962–1963 (95% CI: 1915–1980), which is thought to be the
origin of all 6a strains in China. Upward from the base, there
appeared a trend of 6a migration first to Yunnan, to Guangxi,
Table 2. HCV genotype distribution.
Years of age Gender By injection Years of drug use Needle sharing
#30 31–40 $41 Mean ± SD Male Female Yes No #2 .2 Yes No
6a (n=70) 30 32 8 32.867.6 67 3 61 9 25 45 34 36
3a (n=42) 12 25 5 34.166.2 40 2 36 6 9 33 19 23
1b (n=13) 2 9 2 35.368.3 13 0 13 0 4 9 7 6
3b (n=3) 1 1 1 35.368 . 5 3 03 01 2 1 2
Multiple (n=8) 4 3 1 32.066 . 9 8 08 03 5 6 2
doi:10.1371/journal.pone.0028006.t002
HCV 6a Phylogeography in China
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e28006HCV 6a Phylogeography in China
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e28006then to Guangdong, and recently from Guangdong to many other
regions. Branched from the base, cluster V includes 16 isolates,
descended from a common ancestor dated around 1989 (95% CI:
1984–1994). Except two that were from blood donors in Vietnam,
all isolates in cluster V were from IDUs in China: 2 from
Pingxiang, a city of the Guangxi Province [6], 5 from Honghe and
Wenshan, Prefectures of the Yunnan Province [10], and 7 from
Wuhan City of the Hubei Province [2]. The former three areas
border Vietnam, while the latter is located in central China.
Cluster V may illustrate 6a migration from Vietnam to the
bordering Guangxi and Yunnan provinces and then transport by
IDUs from Yunnan to inland China, over a long distance
following a known drug trafficking route [2]. However, this cluster
seemed to not link to the main 6a prevalence in the country. The
main prevalence appeared to have originated from a different but
older ancestor dated around 1978 (95% CI: 1969–1986). From the
latter, cluster IV was branched, containing 14 isolates all from
IDUs in Pingxiang City of the Guangxi Province [6]. However,
cluster IV isolates have not been found elsewhere, possibly due to
under-estimation. A similar situation was seen for clusters VI and
VII, which link to ancestors dated around 1993 (95% CI: 1989–
1995) and 1994 (95% CI: 1990–1996). Cluster VI and VII may
represent emerging 6a strains only found among IDUs in Shanwei
City. In contrast, cluster II and III isolates showed a wider range of
geographic distribution. Derived from a common ancestor dated
around 1992 (95% CI: 1987–1994), cluster III contains 42 isolates:
36 from Guangdong and 6 from other provinces (Hunan, Yunnan,
Shanghai, Guangxi, and Hubei). Cluster II was descended from an
ancestor slightly younger and contains 21 isolates: 17 from
Guangdong and 4 from other provinces (Fujian, Zhejiang, Shanxi,
and Hubei). Clusters II and III both showed 6a migration inside
Guangdong followed by outward movement to other regions.
Since most were from blood donors [9], a transition from IDU to
non-IDU dissemination is suggested. Remarkably, isolates in
cluster I had the largest number size (135 isolates) and showed the
widest range of spread (11 provinces). It started from a common
ancestor dated around 1990 (95% CI: 1986–1993) and is
characteristic of geographic lineages. For example, sequences
from three cities of Guangxi Province [3,6] formed a noticeable
group analogous to four smaller neighboring groups that contain
sequences mainly from Guangdong and occasionally from other
provinces [8,9]. At the top of the tree, there is a large group
containing two additional geographic lineages, one from Bingyang
City in the Guangxi Province [6] and the other from Wuhan City
in the Hubei Province [2], separated by a bunch of sequences from
Guangdong [8,9]. This large group can be the evidence to support
that the IDU networks in cities of Guangxi, Guangdong and
Hubei provinces had been exchanged. Although Guangxi is
thought to be the origin of 6a in Guangdong, migration from
Guangdong back to Guangxi is also suggested. As 6a in
Table 3. Multiple HCV infections among 8 drug users.
ID NS5 E1 Core*
Injection
user
Sharing
equipments
Years of
drug use
No. clones Genotype clusters/close
" No. clones Genotype clusters/close
" No. clones Genotype
SW33 2 6a VI 6 6a VI Yes Yes .10 years
3 6a III
SW60 4 3a SW100 3 3a SW100 2 3a Yes No ,1year
26 a I 26 a
SW62 2 6a VI 5 6a VI 5 6a Yes Yes 6–7 years
36 a I
SW64 2 6a VI 5 6a VI 5 6a Yes Yes 10 years
3 6a GZ0565
21 b B
SW81 2 6a GZ0329 5 6a GZ0329 5 6a Yes No ,1year
33 a
SW109 2 6a I 5 6a I 5 6a Yes Yes 10 years
3 6a III
21 b S W
SW122 4 1b SW30 4 1b SW30 Yes Yes ,1 year
2 6a III 2 6a III
SW179 2 6a I 3 I Yes Yes 7–8 years
36 a V I 2 V I
*Genotyping 6a with core region can not differentiate clusters, because of the high similarity of the nucleotides.
"Not classifiable into clusters. this isolate was close to a reference.
doi:10.1371/journal.pone.0028006.t003
Figure 1. Subtype 6a phylogenies estimated from (A) E1 and (B) NS5B region sequences, corresponding to H77 nucleotide
positions of 869–1289 and 8276–8615, respectively. Subtype 6b sequence D84262 was used as an outgroup. Green pies label sequences from
our previous studies [8,9]. Red and yellow pies label sequences from this study, in which yellow pies mark isolates from IDUs with multiple HCV
infections. Sequences without pies were retrieved from Genbank. In each tree, five rectangles highlight the further classification of 6a isolates into I, II,
III, VI, and VII clusters. Scale bar represents 0.02 nucleotide substitutions per site.
doi:10.1371/journal.pone.0028006.g001
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recent trend of radiation to other regions. This is brightly
portrayed in cluster I, which showed 6a migrations from
Guangdong to Yunnan, Fujian, Jiangxi, Hainan, Hunan,
Xinjiang, Shanghai, and Shanxi Provinces, and this is associated
with blood donors. Similar phylogeographies were also plotted
under two other models (Table 4 & Figure S3, S4), and
collectively, the 6a migration routes in China were suggested
(Figure 3).
(7) Migration test. To test for the presence of
phylogeographic structures, an additional test was performed to
estimate two statistics: AI (Association Index) and PS (Parsimony
Score statistic). AI is the sum across all the internal nodes of a
phylogeny, which explicitly takes into account the shape of the
phylogeny by measuring the imbalance of the internal nodes [18].
The estimation of PS, however, uses a parsimony approach to
reconstruct the character states at ancestral nodes and calculate
the number of state changes in the phylogeny [19]. According to
sampling origins, the 285 sequences were divided into five states
(Guangdong, Guangxi, Yunnan, Others, and Vietnam).
Correlating the five states with phylogenetic positions showed
the AI and PS statistics both strongly rejecting the null hypothesis
of panmixis [20]. Therefore, association between lineages and
geographic origins was supported.
(8) Bayesian Skyline Plots (BSPs). Figure 4 shows the
overlapped BSPs estimated based on three models (Table 4).
These are flexible, non-parametric estimates of past changes in
population size [11], plotted using the ‘‘log’’ files and ‘‘trees’’ files
resulting from three coalescent procedures. Estimated under
different models, surprisingly similar patterns of growth were
shown. Let’s first describe the BSP from the exponential model. A
relatively constant population size was maintained from 1980 to
around 1994. However, this was breached by a fast exponential
growth until 1998. Since 1998, the growth was suddenly slowed
and then kept slightly upward till the present. The rapid growth
from 1994 to 1998 corresponded to a period when contaminated
plasma collection was common in China, which led to about
500,000 blood donors infected with HCV [21,22] and 300,000
donors infected with HIV [23,24]. The abrupt slowing around
1998, however, was concurrent to a time point when the Chinese
government outlawed the use of paid blood donors, which went
into effect that year [25]. Using slightly lower substitution rates
(Table 4), the BSPs under two other models showed both the start
and end of the rapid growth a little earlier (Figure 4). However,
they remained coincident with the period when for-profit plasma
collection was common in China, which began in the early 1990 s
and was officially forbidden in 1996 [23,24].
Discussion
In this study, both E1 and NS5B sequences of HCV were
determined among 136 drug users. It resulted that 6a was
detected in 70 users (51.5%). The identified 6a predominance is
consistent with that from previous reports [2,3,6,10,26–28].
These previous reports have collectively shown increasing 6a
predominance accounting for a pooled rate of 36.7% [5]. Similar
to that we have recently described, the majority of 6a isolates in
this study were classified into three clusters, I, II, and III, with
more in cluster III than in cluster II and more in cluster I than in
both clusters II and III. In addition, two new clusters, VI and
VII, were designated with the isolates exclusively from the present
study. Including the reference sequences to indicate their
geographic origins showed that isolates in clusters II and III
were mainly from Guangdong and occasionally from other
regions. Isolates in cluster I were not only from a variety of people
(IDUs, patients, and blood donors) in Guangdong, but also from
blood donors in 12 other provinces: Guangxi, Hainan, Yunnan,
Fujian, Jiangxi, Hunan, Hubei, Jiangsu, Zhejiang, Shanghai,
Shanxi, and Xinjiang [2,3,6,8,9]. With the addition of clusters IV
and V, the distribution of 6a in China is illustrated. However,
Vietnam was estimated to be the origin of 6a in China.
Phylogeographic analysis indicated that the Guangxi Province,
which borders Vietnam, could have been the first region to
accept 6a for circulation. Migration from Yunnan, which also
borders Vietnam, might be equally important, but was only
detected among IDUs in limited regions. From Guangxi, 6a
Table 4. Statistics generated from three coalescent processes.*
Combination Models BSP + Exponential" BSP + Lognormal{ BSP + Strict clock{
Posterior 214904.78(214987.10,214823.27)
61.99
215029.4017(215107.40,214946.99)
61.66
215439.89(215571.56,215324.75)
63.47
treeRootHeight 53.42(30.14,94.00)61.04 47.95(36.61,62.19)64.11610
21 70.40(50.41,97.38)65.59610
21
Alpha 0.893(0.889,0.898)64.39610
25 0.905(0.899,0.902)63.61610
25 0.724(0.616,0.842)68.30610
24
PInv 0.468(0.467,0.469)67.95610
26 0.468(0.467,0.470)61.04610
25 0.398(0.346,0.450)63.27610
24
mean.Rate 2.45610
23(2.43610
23,2.47610
23)
61.31610
27
2.07610
23(1.95610
23,2.18610
23)
62.54610
26
N/A
uced/ucld/
clock.mean
2.735610
23(2.706610
23,2.764610
23)
61.72610
27
2.062610
23(2.042610
23,2.082610
23)
61.11610
27
1.690610
23(1.103610
23,2.231610
23)
61.23610
25
COV 0.842(0.840,0.844)69.94610
26 0.547(0.544,0.549)61.26610
25 N/A
covariance 5.652610
24(20.001,2.237610
23)
68.90610
26
2.944610
22(2.664610
22 ,3.248610
22)
61.59610
25
N/A
Treelikelihood 213153.50(213198.88,213110.30)
61.46
213180.23(213223.35,213133.07)
61.43
213350.17(213392.29,213309.21)
68.72610
21
*BSPs were estimated through the three processes and shown in Figure 4. BF=11.371, when the exponential model compared with the Lognormal model; BF=72.79,
when the Lognormal model compared with the strict clock model.
"Using the rate 2.737610
23 (1.792610
23,3.745610
23)61.51610
25 as a prior, and the resulting MCC tree was shown in Figure 2.
{Using the rate 2.062610
23 (1.479610
23,2.869610
23)69.94610
26 as a prior, and the MCC tree was shown in Figure S3.
{Directly estimated from the 285 sequences, and the MCC tree was shown in Figure S4.
doi:10.1371/journal.pone.0028006.t004
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and Hubei provinces. However, there is evidence to show that
only in Guangdong has 6a become a local epidemic, which has
made Guangdong the second source region to disseminate 6a
strains to other regions. A map of 6a migration in China is
therefore portrayed (Figure 3). The importation of 6a from
Vietnam to Guangxi could be attributed to the growing
communications among residents living on both sides of the
Guangxi-Vietnam border, and more importantly, the free
exchange of IDU networks in Guangxi and Southeast Asian
countries through the known drug trafficking routes. Apart from
this, there are three other possibilities: (1) during the late 1970 s,
the Guangdong, Guangxi, and Hainan Provinces accepted over
300,000 refugees from Vietnam, of which a fraction of people
might have been infected [9]; (2) 6a may be indigenous in
Guangdong and Guangxi, since the two regions are geograph-
ically adjacent and historically linked to Vietnam; (3) some 6a
strains might have come from Hong Kong, which had an
alternative route of 6a introduction [29]. In this study,
phylogenetic and phylogeographic analyses both revealed a
certain degree of differences among seven 6a clusters and several
branches, but not comparable with those existing among the
Vietnamese isolates at the tree base. Such differences are not
sufficient to validate possibilities (1) and (2). Unfortunately, due to
lack of a time-stamped sequence dataset from Hong Kong, at the
moment we were unable to test possibility (3). The common
ancestor of 6a strains in China was dated around 1978.
Concurrently, this was the time point when the China-Vietnam
Figure 2. MCC tree estimated under the model of BSP + Uncorrelated Exponential (see Table 4). In addition to the isolates presented in
Figure 1A, sequences determined among 21 blood donors from Vietnam, 22 blood donors from the 12 provinces of China, and 36 IDUs from Liuzhou
City in the Guangxi Province [3] were also included. Branches were colored according to their respective geographic origins. Posterior probabilities
greater than 0.9 were shown at the respective nodes, while the estimated time points of the origin for the nodes were parenthesized. Below the tree
is a time scale from 1960–2010, which measures 6a origin and evolution.
doi:10.1371/journal.pone.0028006.g002
Figure 3. Map of HCV 6a migration in China. With origin from Vietnam, 6a was spread to the neighboring Guangxi and Yunnan Provinces for
circulation (shown in pink arrows). From Guangxi, 6a was further spread to the Guangdong, Hainan, Yunnan, and Hubei provinces (shown in green
arrows), while from Yunnan, 6a was brought by IDUs to the central part of China (shown in a blue arrow). For unknown reasons, 6a has become a
local epidemic in Guangdong and caused infections not only among IDUs, but also among blood donors and patients. As the prevalence is
increasing, Guangdong has become the second source region to radiate 6a to other regions (shown in red arrows).
doi:10.1371/journal.pone.0028006.g003
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region of China to adopt a free market economy and open door
policy. These could be two historical events to facilitate 6a strains
imported from Vietnam (via Hong Kong or other Southeastern
countries?) to China (first to Guangxi, Guangdong, or Yunnan?)
and implanted in an HCV transmission network (via blood donor
or IDU network?). During the decades after 1978, Guangdong
has led the country in fast economic development and has now
become a ‘‘World Production Center’’. The powerful economy
has stimulated a large population of IDUs and the prosperity of
drug trafficking and trading, as well as countless visitors for
business and pleasure. More importantly, tens of millions of
migrants or ‘‘farm workers’’ have been attracted from rural areas
to work in the myriad of factories in the Pearl River Delta, a
central region of the Guangdong Province. However, due to a
lack of optimal working and living conditions, these migrants are
more vulnerable to viral infections such as HCV and HIV [23].
Some of them may have also been involved in a thriving illegal
sex industry [7] and drugs, while a few may have been HCV
carriers from earlier due to previous contaminated blood
donations. During holidays and busy farming seasons, these
migrants have frequently traveled back and forth between
Guangdong and their rural hometowns; 6a strains may have
been widely transported.
Blood transfusion was a major risk factor for HCV infection
before the virus was identified in 1989. This risk remained high in
China even during the mid 1990 s and peaked in 1995. Marked
with a scandalous plasma campaign during 1994–1996 in the
Henan province, it led to more than 500,000 blood donors that
were infected with HCV and 300,000 donors infected with HIV
[21–25]. Most of the infections were acquired at paid blood
donation stations, some operated by local health officials, where
many donors’ red blood samples were mixed, the plasma
extracted, and the pooled red blood cells transfused into the
donors. Similar contaminated donations have been also reported
in seven other provinces [23]. This disastrous event in China was
vitally indicated in the BSPs, which showed a rapid growth in the
HCV-infected population size during 1994–1998. In 1998, the
Chinese government outlawed the use of paid blood donors to
eliminate this risk [25]. Correspondingly, this was reflected in
BSPs with an abrupt slowing in the 6a-infected population size,
starting from 1998. However, in the poor rural communities a
huge infected population has been established, of whom many
have now moved with millions of migrant laborers to cities.
Through drugs and sex, they still provide a bridge to the general
population, and in the BSPs this could be represented with a
slightly increasing slope.
Materials and Methods
Subjects and specimens
Serum samples were collected in Nov 2010 from 210 drug users
retained in a mandatory detoxification center in Shanwei City,
Guangdong Province, China. The ethical review committee of the
Guangzhou Blood Center had approved this study. Guidelines set
by this committee were strictly followed and written informed
consent was obtained from each participant. Before bleeding, a
questionnaire was answered by each user. Questions included the
home address, age, gender, marital status, education, ethnic and
geographic origins, histories of blood transfusion and surgery and
other exposures, time of starting, the duration, and the method of
drug use.
Anti-HCV and NAT assays
Anti-HCV was assayed as previously described [9]. NAT for
HCV RNA was tested on the Procleix TIGRIS system (Novartis
Diagnostics, Emeryville, CA, USA) following the manufacturer’s
protocol.
Figure 4. The overlapped BSPs. Three indicated solid lines represent the estimated effective population sizes through time under three
combination models: BSP + Uncorrected Exponential, BSP + Uncorrected Lognormal, and BSP + Strict Clock, respectively. The colored areas
(pink=Exponential, blue=Lognormal, and yellow=Strict) around the solid lines represent the 95% highest posterior density confidence intervals for
these estimates. The vertical ruler on the left scales the effective population size while the horizontal ruler on the bottom measures time.
doi:10.1371/journal.pone.0028006.g004
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analysis
HCV E1 and NS5B genes were amplified and sequenced as
previously described [8,9]. To confirm multiple HCV infections,
amplicons were cloned into a pT-Adv vector (Advantage PCR
cloning kit; Clontech). A number of clones were picked and
plasmids sequenced [30]. According to HCV subtypes, the
resulting sequences were aligned with references using the
CLUSTAL_X program. Phylogenetic trees were estimated using
the maximum likelihood method under the GTR+I+C6 substitu-
tion model.
Evolutionary analysis of 6a sequences
For coalescent analyses, time-stamped E1 sequences were
further determined among 21 blood donors from Vietnam, 22
blood donors from 12 provinces of China, and 36 IDUs from
Liuzhou City in the Guangxi Province [3]. In addition, 139
sequences were retrieved from Genbank. Together with those
determined in this study, a total of 285 6a isolates were
represented. They all had their sampling dates (from 1992 to
2010) and geographic origins recorded and E1 gene sequences (up
to 519 nt) available to compile the dataset. Information from
Genbank, from original publications, and from our personal
communications were used to verify the sampling dates, to ensure
that no sequences were from experimental animals, engineering,
no multiple quasispecies were included, nor those that were from
single individuals at different time points. Because the change in
HCV-infected population size was an object of study, closely
related 6a sequences from single epidemic scenarios were not
excluded except when they were identical. After alignment and
visual corrections, the most appropriate site model was determined
using the program jModelTest [12].
Based on the 285 sequences, the evolutionary rate and epidemic
historywasestimatedusingthe BEASTpackage [13].Each MCMC
samplingwasperformed for200millionstates,samplingatreeevery
20,000 states. Prior to MCMC, selection was made for (1) site
model, (2) demographic model, and (3) clock model. For (1), the
GTR+I+C model was revealed to be the best among 24 models,
based on the criteria from jModelTest. For (2), although the
constant size, exponential growth, logistic growth, expansion
growth, and BSP all are selectable, a previous study has shown
that, excluding BSP, other models consistently performed poorly
with HCV sequences [14]. Therefore, we did not test these models
but only used the BSP in this study. For (3), we tested all three
models: exponential, lognormal, and strict, in combination with
BSP respectively, for selecting the best-fitting combination. To
analyze the results from the MCMC process, a program Tracer was
used [13]. We used it to estimate the marginal likelihoods of the
trace, check the trace distribution for convergence, and determine if
sufficient ESS (.200) was achieved. We also used it to compute a
BF for each pair of models for selecting the statistically best. In
addition, we used it to reconstruct BSP to show the epidemic history
of HCV. Through the MCMC process, the BSP generalizes skyline
plots from the targeted sequence dataset, then samples the
distribution of the generalized skyline plots, and combines the plots
to yield a posterior distribution of effective population size through
time. Since credibility intervals are provided for effective population
size at every point in time, from the present back to the most recent
common ancestor of the sampled sequences, a past history of HCV-
infected population size is inferred [11].
After discarding 10% of burn-in, a time-scaled phylogeny was
estimated from a posterior distribution of trees that were generated
under a given model combination. We used the TreeAnnotator
program to construct this phylogeny, which best summarizes the set
of credible trees and is called the MCC tree. Since a molecular clock
was used in the MCMC process, the branch lengths and node
height of the tree are in units of years. Phylogeographic structure
was then displayed using the FigTree program, and clades and
lineages were colored according to their geographic origins [13].
In addition, the Befi-BaTS program was used to test for the
presence of statistically significant phylogeographic structure
(www.lonelyjoeparker.com/?tag=befi-bats). This was done
through a parametric bootstrap process, which randomizes the
association a large number of times, calculates statistics from each
randomization, and provides a null distribution of the statistics
with 0.95 credible intervals. Against this level the observed
statistics are compared. Here, the null hypothesis of panmixis
assumes that there is no correlation between phylogeny and taxa
location [19], and the randomization is performed against a series
of tree-shaped statistics. We performed randomizations across a
posterior distribution of trees generated from the MCMC process
under a given coalescent model. During the bootstrapping process,
the phylogenetic uncertainties were correctly incorporated and
phylogeographic structure tested [20].
Nucleotide sequence accession numbers
The sequences reported in this paper have been deposited in
GenBank with the following accession numbers: JF720958-
JF721322.
Supporting Information
Figure S1 Subtype 1b phylogenies estimated from (A)
E1 and (B) NS5B region sequences, corresponding to
H77 nucleotide positions of 869–1289 and 8276–8615,
respectively. Subtype 1a sequence M62321 was used as an
outgroup. Green pies label sequences from our previous studies
[8,9]. Red and yellow pies label sequences from this study, in
which yellow pies mark isolates from IDUs with multiple HCV
infections. Sequences without pies were retrieved from Genbank.
In each tree, six rectangles highlight the further classification of 1b
isolates into A, B, C, D, E, and SW clusters. Scale bar represents
0.05 nucleotide substitutions per site. Bootstrap support values are
shown in italics.
(TIF)
Figure S2 Subtype 3a phylogenies estimated from (A) E1
and (B) NS5B region sequences, corresponding to H77
nucleotide positions of 869–1289 and 8276–8615, respec-
tively. Subtype 3b sequence D49374 was used as an outgroup.
Two geographic clusters were shown with sequences from Hubei
[2] and Yunnan [10] provinces to compare with a geographic
cluster from Guangdong. Otherwise, all labels are the same as
those described in the Figure 1 legend.
(TIF)
Figure S3 MCC tree estimated under the model of BSP
+ Uncorrelated Lognormal (Table 4). See Figure 2 for
legend.
(TIF)
Figure S4 MCC tree estimated under the model of BSP
+ Strict Clock (Table 4). See Figure 2 for legend.
(TIF)
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